Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substancesArticle Published on 2022-11-012022-11-15 Journal: Environment international [Category] 진단, [키워드] 95% CI adjusted affected analyses Analysis anti-Spike IgG antibody antigenic association coefficient comparable Concentration confidence interval Coronavirus disease 2019 COVID-19 COVID-19 antibody COVID-19 vaccination COVID-19 vaccine disease Enrollment examined follow-up study group Human IgG increase in interquartile range magnitude neutralizing antibody observation Occurrence other variables participant Perfluoroalkyl substances PFAS Polyfluoroalkyl substances recent reduced repeated measure reported response serum shown spring sulfonic acid Tetanus vaccination Vaccine vaccine-induced antibody vaccine. [DOI] 10.1016/j.envint.2022.107537 PMC 바로가기
SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 VariantsArticle Published on 2022-10-262022-11-15 Journal: mBio [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome advanced age analyzed antibodies antibody antibody durability Antibody titer circulation Cohort collected convalescent coronavirus coronavirus disease COVID-19 decrease detectable determine Effectiveness Enrollment exceptional female Health care worker highlight immune responses Increases Infection initial limit Longevity median modeling mounted new SARS-CoV-2 occurred Pandemics participant Participants protection public health crisis Rapid Reinfection risk SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 variant seronegative seropositive seropositive participant severe COVID-19 Sex spike-binding antibodies. stability Steady state vaccination variants of concern viruses [DOI] 10.1128/mbio.01784-22 PMC 바로가기
Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive ageArticle Published on 2022-10-262022-11-15 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 95% CI Adjusting age antibodies antibody approved Biological Chi-square collected data Contraception COVID-19 pandemic COVID-19 vaccination Depression described detectable enrolled Enrollment EUA examined Factor Fisher Health Logistic regression loneliness mechanism menstrual menstrual irregularity mitigate pandemic provided Psychological Rapid test recruited reproductive responsible SARS-CoV-2 SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-COV-2 infection Stress undetectable vaccination variables Whole blood women [DOI] 10.1371/journal.pone.0276131 PMC 바로가기
BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis planArticle Published on 2022-10-202022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory symptom approved BNT162b2 Brazil Care case-control study collected conducted Control COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19-related complication Effectiveness Enrollment Ethics evaluate Evidence Follow-up identify material Mutation Older Patient peer-reviewed performed Pfizer-BioNTech polymerase chain populations positive protocol public health randomized clinical trials Research Ethics Committee reverse transcription RT-PCR SARS-CoV-2 SARS-CoV-2 variants screened seeking Statistical analysis plan Study protocol symptomatic tested vaccination [DOI] 10.1371/journal.pone.0276384 PMC 바로가기
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics studyArticle Published on 2022-10-142022-11-15 Journal: eLife [Category] COVID19(2023년), SARS, 바이오마커, 진단, [키워드] Abuse Accelerator Antibody Response association Biomarker BNT162b2 characterized clinical trial coronavirus Course COVID-19 COVID-19 patients Critical CXCL10 cytokine dataset develop Disease progression Donor drug early IFN signaling Eiger BioPharmaceuticals enrolled Enrollment heterogeneity Host identify immune immune marker immune response immune signature immunological immunology independent individual Infection Infectious disease Inflammation machine-learning majority marker MCP-3 MCP1 Medicine memory Mild mRNA vaccination natural infection outcome Outpatient outpatients Patient Pfizer-BioNTech plasma plasma protein Post-infection predict Predictive Predictive modeling proteomics provided receiving RIG-I SARS-CoV-2 SARS-CoV-2-infected patients severe symptoms Stanford Stanford University subsequent systems immunology T cell T cell memory the antibody response trajectory transcriptomics Vaccine viral shedding Virological viruses viruses. with COVID-19 [DOI] 10.7554/eLife.77943 PMC 바로가기
Local monitoring of SARS-CoV-2 variants in two large California counties in 2021Article Published on 2022-10-112022-11-16 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome Advarra Alpha variant analyzed approved carried caused changed changes in Cohort conducted confidence interval coronavirus COVID-19 Cycle threshold value Delta delta variant effort enrolled Enrollment Epidemiology genomic data Hispanic identify individual institutional review board Laboratory less Los Angele MONITOR Mutation nare nasal offered Older over participant Participants PCR polymerase chain positive Positive test Prevalence proportion public health resulting Sample SARS-CoV-2 SARS-CoV-2 lineage SARS-CoV-2 strain SARS-CoV-2 testing SARS-CoV-2 variant Sequencing sequencing data Spanish specimen specimens statistical study enrollment study period Surveillance swab specimen Symptom tested transported variant variants of concern women [DOI] 10.1038/s41598-022-21481-0 PMC 바로가기
Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses – New Vaccine Surveillance Network, United States, 2016-2021Article Published on 2022-10-072022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] accounted acute respiratory illness Adenovirus analysis antibody-based prophylactics anticipated ARI Atypical calculate Care cause caused children circulation Clinical data clinics Community COVID-19 COVID-19 vaccine current demographic characteristics described Effectiveness eligible enrolled Enrollment estimate Health highlighting hospital Hospitalized Human rhinovirus implementation incidence Infant Infants Influenza Influenza virus Measures medical condition métapneumovirus monoclonal morbidity network New nonpharmaceutical intervention pandemic parainfluenza pathogen pathogen-specific pediatric platform proportion PROTECT respiratory respiratory syncytial virus respiratory virus risk factor RSV SARS-CoV-2 Seven severe disease Surveillance United States vaccination Vaccine virus virus [DOI] 10.15585/mmwr.mm7140a1 PMC 바로가기
The Clinical and Genomic Epidemiology of Rhinovirus in Homeless Shelters-King County, WashingtonArticle Published on 2022-10-072022-11-15 Journal: The Journal of Infectious Diseases [Category] 유전자 메커니즘, 치료기술, [키워드] acute respiratory illness analyzed circulating clinical Community congregate setting coronavirus disease COVID-19 COVID-19 pandemic cross-sectional Enrollment Epidemiology genomic Genomic analysis highest homeless shelter Infection King measure multiplex nasal swabs pandemic participant people experiencing homelessness Prevalence prevalent questionnaire Respiratory illness respiratory pathogen respiratory viral respiratory viral infection respiratory viruses rhinovirus Rhinovirus. RT-PCR Sample sequenced sequenced samples serotype serotypes study period submitted subset Surveillance Symptoms tested Trial virus Washington [DOI] 10.1093/infdis/jiac239 PMC 바로가기
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Codetection With Influenza A and Other Respiratory Viruses Among School-Aged Children and Their Household Members-12 March 2020 to 22 February 2022, Dane County, WisconsinArticle Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] acute respiratory illness acute respiratory syndrome affected another respiratory virus children circulation codetection concurrent coronavirus coronavirus 2 Day demographic Enrollment evaluate household Households individual Influenza nasal Other other respiratory virus participant pathogen polymerase chain positive recruitment respiratory respiratory pathogen respiratory virus respiratory viruses respiratory viruses. SARS-CoV-2 specimen Symptom target tested [DOI] 10.1093/cid/ciac487 PMC 바로가기
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak at a College With High Coronavirus Disease 2019 (COVID-19) Vaccination Coverage-Connecticut, August 2021-September 2021Article Published on 2022-10-032022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval activity acute respiratory syndrome adjusted odds ratio analysis attack Attending Characteristics collected college Community Complete Connecticut coronavirus coronavirus 2 Coverage COVID-19 Delta delta variant demographics Department diagnosed Enrollment genomes higher education highest Infection information investigated laboratory-confirmed Logistic regression multivariate outbreak Phylogenetic relationship provided Public reduce respiratory SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 transmission student suggested uninfected vaccination Vaccine vaccine breakthrough. viral genome sequence [DOI] 10.1093/cid/ciac422 PMC 바로가기